These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32609820)

  • 41. CRISPR-Cas12a
    Li Y; Li T; Liu BF; Hu R; Zhu J; He T; Zhou X; Li C; Yang Y; Liu M
    Chem Commun (Camb); 2020 Oct; 56(83):12526-12529. PubMed ID: 32966423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineered RNA-Interacting CRISPR Guide RNAs for Genetic Sensing and Diagnostics.
    Galizi R; Duncan JN; Rostain W; Quinn CM; Storch M; Kushwaha M; Jaramillo A
    CRISPR J; 2020 Oct; 3(5):398-408. PubMed ID: 33095053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In planta gene targeting can be enhanced by the use of CRISPR/Cas12a.
    Wolter F; Puchta H
    Plant J; 2019 Dec; 100(5):1083-1094. PubMed ID: 31381206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks.
    Hajizadeh Dastjerdi A; Newman A; Burgio G
    BioDrugs; 2019 Oct; 33(5):503-513. PubMed ID: 31385197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current understanding of the cyanobacterial CRISPR-Cas systems and development of the synthetic CRISPR-Cas systems for cyanobacteria.
    Pattharaprachayakul N; Lee M; Incharoensakdi A; Woo HM
    Enzyme Microb Technol; 2020 Oct; 140():109619. PubMed ID: 32912679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
    Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
    Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene Disruption Using Chemically Modified CRISPR-Cpf1 RNA.
    McMahon MA; Rahdar M
    Methods Mol Biol; 2021; 2162():49-60. PubMed ID: 32926377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications.
    Xu X; Hulshoff MS; Tan X; Zeisberg M; Zeisberg EM
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases.
    Altae-Tran H; Kannan S; Demircioglu FE; Oshiro R; Nety SP; McKay LJ; Dlakić M; Inskeep WP; Makarova KS; Macrae RK; Koonin EV; Zhang F
    Science; 2021 Oct; 374(6563):57-65. PubMed ID: 34591643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
    Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
    Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance.
    Babu K; Amrani N; Jiang W; Yogesha SD; Nguyen R; Qin PZ; Rajan R
    Biochemistry; 2019 Apr; 58(14):1905-1917. PubMed ID: 30916546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA.
    Paul B; Chaubet L; Verver DE; Montoya G
    Nucleic Acids Res; 2022 May; 50(9):5208-5225. PubMed ID: 34951457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.
    Esmaeili Anvar N; Lin C; Ma X; Wilson LL; Steger R; Sangree AK; Colic M; Wang SH; Doench JG; Hart T
    Nat Commun; 2024 Apr; 15(1):3577. PubMed ID: 38678031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.
    Jeon Y; Choi YH; Jang Y; Yu J; Goo J; Lee G; Jeong YK; Lee SH; Kim IS; Kim JS; Jeong C; Lee S; Bae S
    Nat Commun; 2018 Jul; 9(1):2777. PubMed ID: 30018371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity profiling of CRISPR system reveals greatly enhanced off-target gene editing.
    Wang Y; Wang M; Zheng T; Hou Y; Zhang P; Tang T; Wei J; Du Q
    Sci Rep; 2020 Feb; 10(1):2269. PubMed ID: 32042045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.